Drug intelligence / Profile preview

ZS-06

Development stage: Preclinical
Lead developer: Zensun

Overview

ZS-06 is a preclinical-stage drug candidate being developed by Zensun (Shanghai) Sci & Tech Co., Ltd. for the treatment of functional constipation. The drug is part of Zensun's research program into energy metabolism-related diseases, which the company began exploring in 2009. As of current public disclosures, the specific molecular target, modality, and mechanism of action for ZS-06 remain proprietary and have not been released.

Beyond the preview

Go deeper on ZS-06.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZS-06.

Explore the full profile